 |
English
|
正體中文
|
简体中文
|
Post-Print筆數 : 27 |
Items with full text/Total items : 109952/140887 (78%)
Visitors : 46340680
Online Users : 250
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
https://nccur.lib.nccu.edu.tw/handle/140.119/50958
|
| Title: | 生殖醫學藥物產品G之業務策略分析─M企業在台灣個案分析
Business strategy analysis of FSH Product G - case study of M company in Taiwan |
| Authors: | 鍾雯華
Chung, Wendy |
| Contributors: | 吳文傑
Wu, Jack
鍾雯華
Chung, Wendy |
| Keywords: | 生殖醫學
FSH |
| Date: | 2010 |
| Issue Date: | 2011-09-29 18:20:15 (UTC+8) |
| Abstract: | The case study provides an analysis of the business strategy and advantages of Company M, a German-based pharmaceutical company and current leader in Taiwan’s reproductive health treatment market. This study reviews how Company M’s follicle-stimulating hormone (FSH) Product G has been able to maintain a leading position in the market despite declining birth rate in Taiwan; the important role of (FSH), an essential hormone in the treatment of infertility; and the study of Company M, the leading pharmaceutical company in the treatment of infertility in the world and in Taiwan. Two major strategies are to establish superior Key Account Management and education programs to further strengthen market leadership position of Product G and further educate public about correct reproductive health treatment. A longer-term strategy is to increase the total Taiwan fertility market through support of Taiwan fertility society and industry to lobby for government funding for IVF subsidy
CH1 Introduction 1
CH2 M Company Profile 2
2.1 Company Background 2
2.2 Business Scope 5
2.3 M Company in Taiwan 8
CH3 Reproductive Health treatment overview 14
3.1 Fertility overview and causes of infertility 14
3.2 Reproductive health treatments 15
Follicle-stimulating hormone (FSH) – Product G 22
CH4 Market Overview 24
4.1 Taiwan reproductive health market overview 24
4.2 Key competitors in the market 27
CH5 Business strategy of M Company Fertility business 31
5.1 Global strategy 31
5.2 Local strategy 34
5.2.1 MS Taiwan Fertility business strategy 35
5.2.2 Product G Sales in Taiwan 36
5.2.3 Product positioning 38
5.3 Recent innovative local projects and practices 40
5.3.1 Fertility society and Fertility Hotline sponsorship 40
5.3.2 Establishing leadership through active industry participation 41
5.4 Competitive Advantage 42
CH6 Conclusion and Recommendation 45
Reference 49 |
| Reference: | 【1】 The Merck Group, www.merck.de
【2】 Merck Serono S.A., www.merckserono.com
【3】 Fertility, www.fertility.com
【4】 Wikipedia, http://en.wikipedia.org
【5】 Merck & Co., www.merck.com
【6】 Ferring Pharmaceuticals, www.ferring.com
【7】 Institut Biochimique SA, www.ibsa.com
【8】 Department of Household Registration Affairs, MOI., www.ris.gov.tw
【9】 Index Mundi, http://www.indexmundi.com
【10】 Drugs.com, www.drugs.com/ |
| Description: | 碩士
國立政治大學
國際經營管理英語碩士學位學程(IMBA)
97933002
99 |
| Source URI: | http://thesis.lib.nccu.edu.tw/record/#G0097933002 |
| Data Type: | thesis |
| Appears in Collections: | [國際經營管理英語碩士學程IMBA] 學位論文
|
Files in This Item:
| File |
Size | Format | |
|---|
| index.html | 0Kb | HTML2 | 408 | View/Open |
|
All items in 政大典藏 are protected by copyright, with all rights reserved.
|
著作權政策宣告 Copyright Announcement1.本網站之數位內容為國立政治大學所收錄之機構典藏，無償提供學術研究與公眾教育等公益性使用，惟仍請適度，合理使用本網站之內容，以尊重著作權人之權益。商業上之利用，則請先取得著作權人之授權。
The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.
2.本網站之製作，已盡力防止侵害著作權人之權益，如仍發現本網站之數位內容有侵害著作權人權益情事者，請權利人通知本網站維護人員(
nccur@nccu.edu.tw)，維護人員將立即採取移除該數位著作等補救措施。
NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(
nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
